Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute

Rhea-AI Summary

Agilent Technologies (NYSE: A) has awarded the prestigious Agilent Thought Leader Award to Dr. David R. Liu, a notable researcher in genome editing. This recognition aims to support Dr. Liu's groundbreaking work on CRISPR applications and genetic diseases. Agilent's funding will enhance research into molecular editing tools such as base and prime editing, which target genetic disorders. Dr. Liu expressed gratitude for the support, while Agilent emphasized its commitment to advancing CRISPR methodologies and genomics profiling tools, contributing to significant scientific advancements.

Positive

• Awarding of Agilent Thought Leader Award to Dr. Liu supports innovative research in genome editing.
• Financial support from Agilent promotes advancements in CRISPR technologies like base and prime editing.

Negative

• None.

Researcher recognized for influential work on genome editing and CRISPR applications

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced Dr. David R. Liu has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of genome editing, Dr. Liu is Professor and Director of the Merkin Institute of Transformative Technologies in Healthcare, Vice-Chair of the Faculty at the Broad Institute of MIT and Harvard, Professor of Natural Sciences and Professor of Chemistry and Chemical Biology at Harvard University, and a Howard Hughes Medical Institute Investigator.

A primary direction of Dr. Liu's work has been a focus on using molecular editing tools such as CRISPR and developing the techniques of base editing and prime editing to study and address genetic diseases at their root cause: the genome. These tools enable targeted "rewriting" of the mutations responsible for the genetic disorders that affect hundreds of millions of people worldwide.

“I’m humbled and excited that our lab has been chosen for this award—a reflection of the creativity and dedication of our students and postdocs,” said Dr. Liu. “We can’t wait to try some new lines of research catalyzed by Agilent’s generous gift as well as their capabilities.”

“The research projects supported by this award will contribute to the continued expansion of CRISPR-based methods including prime and base editing,” said Kevin Meldrum, vice president and general manager of Agilent’s Genomics Division. “We look forward to applying our single guide RNA technology and suite of genomics profiling tools toward supporting the Liu lab’s innovative application of genome editing techniques.”

The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. To learn more, visit the Agilent Thought Leader Award web site.

About Agilent Technologies

Agilent is a leader in life sciences, diagnostics, and applied chemical markets, delivering innovative technology solutions that provide trusted answers to researchers’ most challenging scientific questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005498/en/

Media Contact

Naomi Goumillout

Agilent Technologies

+1.781.266.2819

naomi.goumillout@agilent.com

Source: Agilent Technologies Inc.

FAQ

What is the Agilent Thought Leader Award?

The Agilent Thought Leader Award is given to recognize influential researchers in life sciences, providing financial support and resources to advance their work.

Who is Dr. David R. Liu?

Dr. David R. Liu is a prominent researcher in genome editing and is associated with the Broad Institute and Harvard University.

What research will the Agilent Thought Leader Award support?

The award will support Dr. Liu's research on CRISPR applications and the development of base and prime editing techniques.

How much revenue did Agilent Technologies generate in 2020?

Agilent Technologies generated $5.34 billion in revenue for fiscal year 2020.

What are the main focuses of Agilent Technologies?

Agilent Technologies focuses on life sciences, diagnostics, and applied chemical markets, delivering innovative technology solutions.